drugset
drugset / Trial / NCT06565117

Efficacy of Dipotassium Glycyrrhizinate Emollients in the Maintenance Treatment of Adult Atopic Dermatitis

NCT06565117 ↗

Completed 120 enrolled The Affiliated Hospital of Xuzhou Medical University
RandomizedParallel-groupSingle-blindTreatment

Summary

To investigate whether emollients containing dipotassium glycyrrhizinate have a sustained improvement in the clinical severity of mild to moderate atopic dermatitis in adult.

Timeline

Start
2021-10-01
Primary completion
2023-02-01
Completion
2023-02-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dipotassium Glycyrrhizinate Unknown — Topical

Indications

atopic eczema